Answers are grounded in this paper and cite their sources.
The placenta can be threatened by DNA damage caused by genotoxic events. However, how human placental trophoblasts coordinate cell type-restricted mechanisms in response to DNA damage and how they maintain genome stability remains elusive. Here, we identify transcription factor SP6 as a guardian of genome integrity in human multipotent trophoblasts. Lack of SP6 in human placental trophoblast stem cells (TSCs) or cytotrophoblast (CT) cells leads to the defects in DNA damage repair (DDR). Crucially, SP6 operates independently of its transcriptional network controlling trophoblast fate, instead acting as a scaffold for DNA-PK complex assembly and facilitating phosphatase PP2A to regulate phosphorylation state of DNA-PKcs, a critical step for non-homologous end joining initiation. In addition, the deubiquitinase OTUB1 stabilizes SP6 by cleaving K48-linked ubiquitin chains, coupling SP6 cellular protein turnover to DDR efficiency. Pharmaceutically or genetically targeting OTUB1-SP6 regulatory axis resets the susceptibility of TSCs or placental CT-derived organoids to genotoxic stress-induced DNA damage. Together, these findings identify a human multipotent trophoblast-specific DDR mechanism, and we propose a potential druggable target for mitigating DNA damage and cell senescence-related human placental diseases. SP6 functions as a scaffold for DNA-PK complex assembly and promotes PP2A-mediated dephosphorylation of DNA-PKcs to enable NHEJ DNA repair in human multipotent trophoblast stem cells.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: